Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI.
J Pediatr. 2014 Aug;165(2):319-325.e1. doi: 10.1016/j.jpeds.2014.04.019. Epub 2014 May 22.
To develop a risk assessment model for early detection of hepatic steatosis using common anthropometric and metabolic markers.
This was a cross-sectional study of 134 adolescent and young adult females, age 11-22 years (mean 13.3±2 years) from a middle school and clinics in Madison, Wisconsin. The ethnic distribution was 27% Hispanic and 73% non-Hispanic; the racial distribution was 64% Caucasian, 31% African-American, and 5% Asian, Fasting glucose, fasting insulin, alanine aminotransferase (ALT), body mass index (BMI), waist circumference (WC), and other metabolic markers were assessed. Hepatic fat was quantified using magnetic resonance imaging proton density fat fraction (MR-PDFF). Hepatic steatosis was defined as MR-PDFF>5.5%. Outcome measures were sensitivity, specificity, and positive predictive value (PPV) of BMI, WC, ALT, fasting insulin, and ethnicity as predictors of hepatic steatosis, individually and combined, in a risk assessment model. Classification and regression tree methodology was used to construct a decision tree for predicting hepatic steatosis.
MR-PDFF revealed hepatic steatosis in 16% of subjects (27% overweight, 3% nonoverweight). Hispanic ethnicity conferred an OR of 4.26 (95% CI, 1.65-11.04; P=.003) for hepatic steatosis. BMI and ALT did not independently predict hepatic steatosis. A BMI>85% combined with ALT>65 U/L had 9% sensitivity, 100% specificity, and 100% PPV. Lowering the ALT value to 24 U/L increased the sensitivity to 68%, but reduced the PPV to 47%. A risk assessment model incorporating fasting insulin, total cholesterol, WC, and ethnicity increased sensitivity to 64%, specificity to 99% and PPV to 93%.
A risk assessment model can increase specificity, sensitivity, and PPV for identifying the risk of hepatic steatosis and guide the efficient use of biopsy or imaging for early detection and intervention.
利用常见的人体测量学和代谢标志物开发一种用于早期检测肝脂肪变性的风险评估模型。
这是一项横断面研究,纳入了来自威斯康星州麦迪逊市一所中学和诊所的 134 名 11-22 岁(平均年龄 13.3±2 岁)的青少年和年轻女性。其种族分布为 27%西班牙裔和 73%非西班牙裔;种族分布为 64%白种人,31%非裔美国人,5%亚洲人。评估了空腹血糖、空腹胰岛素、丙氨酸氨基转移酶(ALT)、体重指数(BMI)、腰围(WC)和其他代谢标志物。使用磁共振成像质子密度脂肪分数(MR-PDFF)定量肝脂肪。肝脂肪变性定义为 MR-PDFF>5.5%。观察指标为 BMI、WC、ALT、空腹胰岛素和种族作为肝脂肪变性预测因子的个体和联合的敏感性、特异性和阳性预测值(PPV),并在风险评估模型中进行评估。采用分类和回归树方法构建了预测肝脂肪变性的决策树。
MR-PDFF 显示 16%的受试者存在肝脂肪变性(27%超重,3%非超重)。西班牙裔种族赋予肝脂肪变性的 OR 为 4.26(95%CI,1.65-11.04;P=.003)。BMI 和 ALT 不能独立预测肝脂肪变性。BMI>85%联合 ALT>65U/L 的敏感性为 9%,特异性为 100%,PPV 为 100%。将 ALT 值降低至 24U/L 可将敏感性提高至 68%,但将 PPV 降低至 47%。纳入空腹胰岛素、总胆固醇、WC 和种族的风险评估模型可将敏感性提高至 64%,特异性提高至 99%,PPV 提高至 93%。
风险评估模型可提高识别肝脂肪变性风险的特异性、敏感性和 PPV,并指导有效地进行活检或影像学检查以进行早期检测和干预。